NIP
CLLS

Nicholas Investment Partners’s Cellectis CLLS Stock Holding History

Nicholas Investment Partners’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-18,662
Closed -$513K – 299
2016
Q1 		$513K Sell
18,662
-5,090
-21% -$123K 0.04% 295
2015
Q4 		$737K Buy
+23,752
New +$721K 0.05% 276

Other funds holding CLLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
THSP
Taube Hodson Stonex Partners London, United Kingdom $488M AUM 4.7% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nicholas Investment Partners's CLLS Position: Q2 2016 in Review

Nicholas Investment Partners sold out of Cellectis (CLLS) in Q2 2016, closing a stake of 18,662 shares — an estimated $513K sold.

Nicholas Investment Partners first reported a position in CLLS in Q4 2015 and held it in 2 quarters. The position peaked at $737K in Q4 2015. 38 funds tracked by Wall St. Rank hold CLLS as of Q2 2016.

  • Nicholas Investment Partners reported no remaining Cellectis position as of Q2 2016 after selling out during the quarter.
  • Nicholas Investment Partners sold 18,662 Cellectis shares in Q2 2016, an estimated $513K.
  • Nicholas Investment Partners first reported a position in Cellectis in Q4 2015 and held it in 2 quarters.
  • Nicholas Investment Partners's Cellectis position peaked at $737K in Q4 2015.
  • 38 funds tracked by Wall St. Rank held Cellectis as of Q2 2016.

Based on Nicholas Investment Partners's 13F filing for Q2 2016, filed 12 Aug 2016.